111, Inc. (YI)
NASDAQ: YI · Real-Time Price · USD
6.43
-0.64 (-9.05%)
At close: Aug 29, 2025, 4:00 PM
6.20
-0.23 (-3.58%)
After-hours: Aug 29, 2025, 7:04 PM EDT
111, Inc. Market Cap
111, Inc. has a market cap or net worth of $55.73 million as of August 29, 2025. Its market cap has decreased by -35.59% in one year.
Market Cap
55.73M
Enterprise Value
15.69M
1-Year Change
-35.59%
Ranking
Category
Stock Price
$6.43
Market Cap Chart
Since September 12, 2018, 111, Inc.'s market cap has decreased from $1.11B to $55.73M, a decrease of -95.00%. That is a compound annual growth rate of -34.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 55.73M | 4.43% |
| Dec 31, 2024 | 53.37M | -59.01% |
| Dec 29, 2023 | 130.19M | -48.23% |
| Dec 30, 2022 | 251.48M | -13.30% |
| Dec 31, 2021 | 290.06M | -49.33% |
| Dec 31, 2020 | 572.40M | 4.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.09B |
| Johnson & Johnson | 425.77B |
| AbbVie | 367.55B |
| UnitedHealth Group | 275.22B |
| AstraZeneca | 248.07B |
| Novo Nordisk | 246.45B |
| Novartis AG | 245.68B |
| Abbott Laboratories | 228.80B |